These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 4338459)
1. Symposium: behavior modification by drugs. I. Pharmacology of the amphetamines. Baldessarini RJ Pediatrics; 1972 May; 49(5):694-701. PubMed ID: 4338459 [No Abstract] [Full Text] [Related]
2. Amphetamines, barbiturates, LSD and cannabis: their use and misuse. Rep Public Health Med Subj (Lond); 1970; 124():1-75. PubMed ID: 5527004 [No Abstract] [Full Text] [Related]
3. Use of d-amphetamine and related central nervous system stimulants in children. Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865 [No Abstract] [Full Text] [Related]
4. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children. Eisenberg L Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174 [No Abstract] [Full Text] [Related]
5. [Basic and clinical studies on solvent abuse]. Fukui K Seishin Shinkeigaku Zasshi; 2002; 104(1):66-70. PubMed ID: 11928314 [No Abstract] [Full Text] [Related]
6. Psychoactive drugs in the immature organism. Kornetsky C Psychopharmacologia; 1970; 17(2):105-36. PubMed ID: 4910308 [No Abstract] [Full Text] [Related]
7. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. National Toxicology Program NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031 [TBL] [Abstract][Full Text] [Related]
9. The pharmacological basis of drug dependence. Marlow HF S Afr Med J; 1970 May; 44(21):610-5. PubMed ID: 4316744 [No Abstract] [Full Text] [Related]
10. Hyperkinetic children: the use of stimulant drugs evaluated. Cole SO Am J Orthopsychiatry; 1975 Jan; 45(1):28-37. PubMed ID: 163061 [TBL] [Abstract][Full Text] [Related]
11. [The effect of catecholamines (piridrol and phenamine) on various synaptic systems of the cerebral cortex]. Smirnov GD; Vinogradova VM Biull Eksp Biol Med; 1967 Nov; 63(11):30-3. PubMed ID: 4394704 [No Abstract] [Full Text] [Related]
12. Learning disorders, hyperkinesis, and the use of drugs in children. Oettinger L Rehabil Lit; 1971 Jun; 32(6):162-7 contd. PubMed ID: 5580199 [No Abstract] [Full Text] [Related]
13. A clinical view of the amphetamines. Tinklenberg JR Am Fam Physician; 1971 Nov; 4(5):82-6. PubMed ID: 5117506 [No Abstract] [Full Text] [Related]
14. Neuropharmacology of hyperkinesis. Silbergeld EK Curr Dev Psychopharmacol; 1977; 4():179-214. PubMed ID: 23247 [No Abstract] [Full Text] [Related]
15. Amphetamine et al. O'Shea B Ir Med J; 2000 Jun; 93(4):100-1. PubMed ID: 11037564 [No Abstract] [Full Text] [Related]
16. Behavior and EEG analysis of chronic amphetamine effect. Ellinwood EH; Sudilovsky A; Nelson LM Biol Psychiatry; 1974 Apr; 8(2):169-76. PubMed ID: 4858385 [No Abstract] [Full Text] [Related]
17. Amphetamine: a pharmacological profile. Aboul-Enein HY Am J Pharm Sci Support Public Health; 1971; 143(5):161-4. PubMed ID: 5003217 [No Abstract] [Full Text] [Related]
18. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Rylander G Psychiatr Neurol Neurochir; 1972; 75(3):203-12. PubMed ID: 4625014 [No Abstract] [Full Text] [Related]
19. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Snyder SH Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465 [No Abstract] [Full Text] [Related]
20. Amphetamine-type drugs for hyperactive children. Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553 [No Abstract] [Full Text] [Related] [Next] [New Search]